UNCY
Unicycive Therapeutics Inc
4.20$
-0.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +3.8% | +246.3% | – | – | +130.9% | -52.5% | +2.2% | – | – | +39.7% | – | – | |
| – | – | – | – | – | – | -147.5% | – | – | – | – | – | – | |
| – | +25.5% | +60.9% | -28.5% | -37.4% | +73.7% | -58.9% | -19.4% | +69.4% | -24.1% | -28.6% | +73.5% | – | |
| – | -18.9% | +15.0% | +5.9% | +26.6% | +23.9% | +46.4% | -10.4% | -16.0% | +13.6% | +37.3% | +7.6% | – | |
| – | +6.3% | +41.3% | -17.0% | -15.5% | +48.2% | -13.7% | -12.8% | +5.4% | -1.6% | +13.9% | +23.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.6% | +5.3% | -20.0% | -6.3% | +33.3% | -25.0% | -13.3% | +15.4% | +80.0% | -100.0% | – | – | |
| – | – | – | – | -141.6% | – | – | -1,231.1% | – | – | – | – | – | |
| – | – | – | +2,361.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -141.6% | – | – | -1,231.1% | – | – | – | – | – | |
| – | – | – | – | -140.1% | – | – | -974.4% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.